These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 19805286)

  • 1. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX.
    Alterio V; Hilvo M; Di Fiore A; Supuran CT; Pan P; Parkkila S; Scaloni A; Pastorek J; Pastorekova S; Pedone C; Scozzafava A; Monti SM; De Simone G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16233-8. PubMed ID: 19805286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target.
    De Simone G; Supuran CT
    Biochim Biophys Acta; 2010 Feb; 1804(2):404-9. PubMed ID: 19679200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes.
    Hilvo M; Baranauskiene L; Salzano AM; Scaloni A; Matulis D; Innocenti A; Scozzafava A; Monti SM; Di Fiore A; De Simone G; Lindfors M; Jänis J; Valjakka J; Pastoreková S; Pastorek J; Kulomaa MS; Nordlund HR; Supuran CT; Parkkila S
    J Biol Chem; 2008 Oct; 283(41):27799-27809. PubMed ID: 18703501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties.
    Genis C; Sippel KH; Case N; Cao W; Avvaru BS; Tartaglia LJ; Govindasamy L; Tu C; Agbandje-McKenna M; Silverman DN; Rosser CJ; McKenna R
    Biochemistry; 2009 Feb; 48(6):1322-31. PubMed ID: 19170619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors.
    Innocenti A; Pastorekova S; Pastorek J; Scozzafava A; De Simone G; Supuran CT
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5825-8. PubMed ID: 19751975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
    Thiry A; Dogné JM; Masereel B; Supuran CT
    Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
    Ferraroni M; Del Prete S; Vullo D; Capasso C; Supuran CT
    Acta Crystallogr D Biol Crystallogr; 2015 Dec; 71(Pt 12):2449-56. PubMed ID: 26627652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
    Guler OO; De Simone G; Supuran CT
    Curr Med Chem; 2010; 17(15):1516-26. PubMed ID: 20166929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Expression and Crystallization System of Cancer-Associated Carbonic Anhydrase Isoform IX.
    Leitans J; Kazaks A; Balode A; Ivanova J; Zalubovskis R; Supuran CT; Tars K
    J Med Chem; 2015 Nov; 58(22):9004-9. PubMed ID: 26522624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.
    Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA
    Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX.
    Hulikova A; Zatovicova M; Svastova E; Ditte P; Brasseur R; Kettmann R; Supuran CT; Kopacek J; Pastorek J; Pastorekova S
    FEBS Lett; 2009 Nov; 583(22):3563-8. PubMed ID: 19861127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
    Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
    Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells.
    Whittington DA; Waheed A; Ulmasov B; Shah GN; Grubb JH; Sly WS; Christianson DW
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9545-50. PubMed ID: 11493685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors.
    Ditte P; Dequiedt F; Svastova E; Hulikova A; Ohradanova-Repic A; Zatovicova M; Csaderova L; Kopacek J; Supuran CT; Pastorekova S; Pastorek J
    Cancer Res; 2011 Dec; 71(24):7558-67. PubMed ID: 22037869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents.
    Winum JY; Rami M; Scozzafava A; Montero JL; Supuran C
    Med Res Rev; 2008 May; 28(3):445-63. PubMed ID: 17880011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides.
    Pastorekova S; Vullo D; Casini A; Scozzafava A; Pastorek J; Nishimori I; Supuran CT
    J Enzyme Inhib Med Chem; 2005 Jun; 20(3):211-7. PubMed ID: 16119190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.
    Svastová E; Hulíková A; Rafajová M; Zat'ovicová M; Gibadulinová A; Casini A; Cecchi A; Scozzafava A; Supuran CT; Pastorek J; Pastoreková S
    FEBS Lett; 2004 Nov; 577(3):439-45. PubMed ID: 15556624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase IX as a target for designing novel anticancer drugs.
    Monti SM; Supuran CT; De Simone G
    Curr Med Chem; 2012; 19(6):821-30. PubMed ID: 22214452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and characterization of novel selective inhibitors of carbonic anhydrase IX.
    Dudutienė V; Matulienė J; Smirnov A; Timm DD; Zubrienė A; Baranauskienė L; Morkūnaite V; Smirnovienė J; Michailovienė V; Juozapaitienė V; Mickevičiūtė A; Kazokaitė J; Bakšytė S; Kasiliauskaitė A; Jachno J; Revuckienė J; Kišonaitė M; Pilipuitytė V; Ivanauskaitė E; Milinavičiūtė G; Smirnovas V; Petrikaitė V; Kairys V; Petrauskas V; Norvaišas P; Lingė D; Gibieža P; Capkauskaitė E; Zakšauskas A; Kazlauskas E; Manakova E; Gražulis S; Ladbury JE; Matulis D
    J Med Chem; 2014 Nov; 57(22):9435-46. PubMed ID: 25358084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saccharin: a lead compound for structure-based drug design of carbonic anhydrase IX inhibitors.
    Mahon BP; Hendon AM; Driscoll JM; Rankin GM; Poulsen SA; Supuran CT; McKenna R
    Bioorg Med Chem; 2015 Feb; 23(4):849-54. PubMed ID: 25614109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.